HomeCompareBPSR vs SCHD

BPSR vs SCHD: Dividend Comparison 2026

BPSR yields 3333.33% · SCHD yields 3.46%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BPSR wins by $1244041712890.37M in total portfolio value
10 years
BPSR
BPSR
● Live price
3333.33%
Share price
$0.06
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1244041712890.40M
Annual income
$1,174,716,366,071,938,000.00
Full BPSR calculator →
SCHD
Schwab U.S. Dividend Equity ETF
● Live price
3.46%
Share price
$30.48
Annual div
$1.06
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.0K
Annual income
$425.95
Full SCHD calculator →

Portfolio growth — BPSR vs SCHD

📍 BPSR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBPSRSCHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BPSR + SCHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BPSR pays
SCHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BPSR
Annual income on $10K today (after 15% tax)
$283,333.33/yr
After 10yr DRIP, annual income (after tax)
$998,508,911,161,147,300.00/yr
SCHD
Annual income on $10K today (after 15% tax)
$294.40/yr
After 10yr DRIP, annual income (after tax)
$362.06/yr
At 15% tax rate, BPSR beats the other by $998,508,911,161,146,900.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BPSR + SCHD for your $10,000?

BPSR: 50%SCHD: 50%
100% SCHD50/50100% BPSR
Portfolio after 10yr
$622020856445.21M
Annual income
$587,358,183,035,969,300.00/yr
Blended yield
94.43%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BPSR buys
0
SCHD buys
3
PoliticianChamberTickerTypeAmountDate
Virginia Foxx🏢 House$SCHD▼ Sell$50,001 - $100,0002023-03-08
Steve Cohen🏢 House$SCHD▲ Buy$50,001 - $100,0002022-07-29
Hakeem S. Jeffries🏢 House$SCHD▲ Buy$15,001 - $50,0002021-04-12
Mikie Sherrill🏢 House$SCHD▲ Buy$100,001 - $250,0002020-02-21
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBPSRSCHD
Forward yield3333.33%3.46%
Annual dividend / share$2.00$1.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$1244041712890.40M$29.0K
Annual income after 10y$1,174,716,366,071,938,000.00$425.95
Total dividends collected$1239274250481.68M$3.9K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: BPSR vs SCHD ($10,000, DRIP)

YearBPSR PortfolioBPSR Income/yrSCHD PortfolioSCHD Income/yrGap
1← crossover$344,033$333,333.33$11,226$346.36+$332.8KBPSR
2$11,085,665$10,717,549.33$12,572$357.38+$11.07MBPSR
3$334,616,633$322,754,971.08$14,046$367.84+$334.60MBPSR
4$9,462,934,690$9,104,894,892.71$15,660$377.73+$9462.92MBPSR
5$250,766,259,005$240,640,918,887.41$17,425$387.07+$250766.24MBPSR
6$6,228,082,462,189$5,959,762,565,053.11$19,354$395.86+$6228082.44MBPSR
7$144,998,525,500,125$138,334,477,265,582.72$21,461$404.13+$144998525.48MBPSR
8$3,165,074,899,913,431$3,009,926,477,628,297.00$23,762$411.89+$3165074899.89MBPSR
9$64,790,043,755,570,470$61,403,413,612,663,110.00$26,272$419.15+$64790043755.54MBPSR
10$1,244,041,712,890,398,500$1,174,716,366,071,938,000.00$29,010$425.95+$1244041712890.37MBPSR

BPSR vs SCHD: Complete Analysis 2026

BPSRStock

Organicell Regenerative Medicine, Inc. processes, distributes, and supplies biologically processed cellular and tissue-based products in the United States. The company was formerly known as Biotech Products Services and Research, Inc. and changed its name to Organicell Regenerative Medicine, Inc. in June 2018. Organicell Regenerative Medicine, Inc. has an agreement with Regenerative Care Network to study potential therapeutic benefits of Zofin for patients with heart failure. Organicell Regenerative Medicine, Inc. was founded in 2011 and is headquartered in Miami, Florida.

Full BPSR Calculator →

SCHDETF

The fund’s goal is to track as closely as possible, before fees and expenses, the total return of the Dow Jones U.S. Dividend 100 Index.

Full SCHD Calculator →
📬

Get this BPSR vs SCHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BPSR vs JEPIBPSR vs OBPSR vs KOBPSR vs MAINBPSR vs VYMBPSR vs DGROBPSR vs VIGBPSR vs HDV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.